Researchers at University of California San Diego School of Medicine have discovered differences in brain circuitry that contribute to starvation and weight loss in people with anorexia nervosa.
From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages.
The San Diego Supercomputer Center at UC San Diego has announced the launch of ‘HPC Share’, a data sharing resource that will enable users of the Center’s high-performance computing resources to easily transfer, share, and discuss their data within their research teams and beyond.
Netherton syndrome is exacerbated by the presence of Staphylococcus aureus and Staphylococcus epidermidis living on human skin report University of California San Diego School of Medicine researchers.
An international team of scientists, led by UC San Diego researchers, has developed a new, multi-sensor tool that measures subtle changes in multiple sclerosis patients, allowing physicians to more frequently and more quickly respond to changes in symptoms or patient condition.
A comparison of normal and germ-free mice revealed that as much as 70 percent of a mouse’s gut chemistry is determined by its gut microbiome. Even in distant organs, such as the uterus or the brain, approximately 20 percent of molecules were different in the mice with gut microbes.
A new study at UC San Diego, published February 11, 2020, found that exposure to heatwaves during the last week of pregnancy was strongly linked to an increased risk of preterm delivery – the hotter the temperature or the longer the heatwave, the greater the risk.
UC San Diego researchers suggest that prolonged exposure to a pair of antioxidant proteins may contribute to enlargement of the liver and fatty liver diseases.
UC San Diego announced a gift from Nissi and Ajit Varki, both professors at the university. The gift has been designated for the Center for Academic Research and Training in Anthropogeny (CARTA) to support a broad range of activities, including scholarly studies of the origins of humankind.
UC San Diego bioengineers developed a control system that could make CAR T-cell therapy safer and more powerful when treating cancer. By programming CAR T cells to switch on when exposed to blue light, the researchers controlled the cells to destroy skin tumors in mice without harming healthy tissue